Immunic’s (IMUX) Buy Rating Reaffirmed at B. Riley
B. Riley reissued their buy rating on shares of Immunic (NASDAQ:IMUX – Free Report) in a report released on Friday morning,Benzinga reports. The firm currently has a $5.00 price target on the stock, down from their prior price target of $6.00. IMUX has been the topic of several other reports. HC Wainwright reiterated a “buy” […]
B. Riley reissued their buy rating on shares of Immunic (NASDAQ:IMUX – Free Report) in a report released on Friday morning,Benzinga reports. The firm currently has a $5.00 price target on the stock, down from their prior price target of $6.00. IMUX has been the topic of several other reports. HC Wainwright reiterated a “buy” […]
